Publication | Closed Access

Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs

Novel TherapyHepatocellular CarcinomaImmunologyAnti-tumor ImmunityTumor TargetingLiver CancerMedicineRadiation OncologyTumor MicroenvironmentGo-based Pd-l1 Sirnas